Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8481070
APP PUB NO 20100021553A1
SERIAL NO

12570039

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There is provided a powder formulation for nasal delivery including a protein having a molecular weight of 10 kDa or greater and chitosan or a derivative thereof or a salt of chitosan or a salt of a derivative of chitosan. Preferably the protein is human growth hormone.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARCHIMEDES DEVELOPMENT LIMITEDNOTTINGHAM NG7 2TN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cheng, Yu-Hui Nottingham, GB 8 69
Dyer, Ann Margaret Nottingham, GB 6 36
Smith, Alan Nottingham, GB 148 2170
Watts, Peter James Nottingham, GB 31 584

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 9, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00